New Key Statistics Module, Z-Score and F-Score
NAS:ADPT Key Ratios
| Market Cap $ M | 943.03 |
| Enterprise Value $ M | 791.33 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.22 |
| Price/Sales | 5.28 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 177.00 |
| EPS (TTM) $ | -1.34 |
| Beneish M-Score | -2.71 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -20.60 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.25 |
| EV-to-EBITDA | -4.78 |
| PEG | -- |
| Shares Outstanding M | 147.58 |
| Net Margin (%) | -110.13 |
| Operating Margin % | -94.28 |
| Pre-tax Margin (%) | -110.19 |
| Quick Ratio | 3.38 |
| Current Ratio | 3.52 |
| ROA % (ttm) | -31.06 |
| ROE % (ttm) | -69.21 |
| ROIC % (ttm) | -51.52 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.79 |
ADPT Number of Guru Trades
ADPT Volume of Guru Trades
Gurus Latest Trades with NAS:ADPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ADPT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Adaptive Biotechnologies Corp Insider Transactions
No Available Data
News about NAS:ADPT
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers